H.C. Wainwright Starts Rapport Therapeutics (RAPP) at Buy
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Price: $47.42 +0.13%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao initiates coverage on Rapport Therapeutics (NASDAQ: RAPP) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Rapport Therapeutics click here. For more ratings news on Rapport Therapeutics click here.
Shares of Rapport Therapeutics closed at $14.43 yesterday.
You May Also Be Interested In
- Rapport Therapeutics (RAPP) PT Raised to $66 at H.C. Wainwright
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
